Ticker Scorecard - XBIT Basics Company: XBiotech Inc. Common Stock IPO Date: April 13, 2015 Sector: Healthcare Industry: Biotech Market Cap: $91.15M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 2.94% Avg Daily Range (30 D): $0.12 | 3.24% Avg Daily Range (90 D): $0.18 | 3.31% Institutional Daily Volume Avg Daily Volume: .12M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .04M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 77 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 187 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.6M Avg Closing Trade (30 D): $.93M Avg Closing Trade (90 D): $.93M Avg Closing Volume: 225.81K     News Jan 14, 2025 @ 9:37 PM Wolf Haldenstein Adler Freeman & Herz LLP announce... Source: Wolf Haldenstein Adler Freeman & Herz Llp Dec 24, 2024 @ 12:53 AM XBiotech suspend son programme de rhumatologie Source: N/A Dec 24, 2024 @ 12:53 AM XBiotech setzt Rheumatologieprogramm aus Source: N/A Aug 23, 2024 @ 3:51 PM Cancer Cachexia Market Forecasted to Reach $3.14 B... Source: Researchandmarkets.Com Jun 19, 2024 @ 7:31 PM Ergebnisse aus randomisierter, doppelt verblindete... Source: XBiotech Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.07 $-.16 $-.43 Diluted EPS Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -32.66M $ -5.02M $ -13.01M Operating Income / Loss $ -42.31M $ -7.9M $ -14.97M Cost of Revenue $ $ $ Net Cash Flow $ -19.07M $ -6.12M $ -11.96M PE Ratio